Crescent Biopharma, Inc. is a biotechnology company. The Company is focused on advancing the next wave of therapies for cancer patients. The Companyâs pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. The Companyâs lead program is CR-001, a tetravalent PD-1 x VEGF bispecific antibody in development for the treatment of solid tumors, and it is also advancing CR-002 and CR-003, antibody drug conjugates (ADCs) with topoisomerase inhibitor payloads. CR-002 and CR-003 are ADCs designed to deliver clinically active cytotoxic drugs known as topoisomerase inhibitors to tumor cells. Each of these programs has the potential to deliver therapeutics with clinical efficacy both as a monotherapy and in combination with CR-001 with significant potential across solid tumor indications.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļ- -
āļāļ·āđāļāļāļĢāļīāļĐāļąāļ- -
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļ- -
āļāļĩāļāļĩāđāļ- -
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ- -
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒ- -
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļ- -
āļāļĩāđāļāļĒāļđāđ- -
āđāļĄāļ·āļāļ- -
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđ- -
āļāļĢāļ°āđāļāļĻ- -
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ- -
āđāļāļĢāļĻāļąāļāļāđ- -
āđāļ§āđāļāđāļāļāđ- -
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļ- -
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļ- -
āļāļĩāļāļĩāđāļ- -
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
Dr. Ellie Eunkyung Im
Chief Medical Officer
Mr. Bruce Johnson
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
Mr. Chinmaya Rath
Senior Vice President, Chief Business Officer
Senior Vice President, Chief Business Officer
Ms. Alexandra (Alex) Balcom, CPA
Ms. Alexandra (Alex) Balcom, CPA
Independent Director
Mr. Joshua (Josh) Brumm
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. Peter Harwin
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
Mr. David Charles Lubner, CPA
Mr. David Charles Lubner, CPA
Independent Director
Dr. Susan M. Moran, M.D.
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
Dr. Ellie Eunkyung Im
Chief Medical Officer
Mr. Bruce Johnson
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
Mr. Chinmaya Rath
Senior Vice President, Chief Business Officer
Senior Vice President, Chief Business Officer
Ms. Alexandra (Alex) Balcom, CPA
Ms. Alexandra (Alex) Balcom, CPA
Independent Director